Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3709836010 | Erlotinib-containing product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
3709837018 | Product containing erlotinib in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Erlotinib-containing product in oral dose form | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
Erlotinib-containing product in oral dose form | Is a | Product manufactured as oral dose form | true | Inferred relationship | Some | ||
Erlotinib-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
Erlotinib-containing product in oral dose form | Has active ingredient | Erlotinib | true | Inferred relationship | Some | 1 | |
Erlotinib-containing product in oral dose form | Is a | Erlotinib-containing product | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Erlotinib only product in oral dose form | Is a | True | Erlotinib-containing product in oral dose form | Inferred relationship | Some | |
Erlotinib (as erlotinib hydrochloride) 100 mg oral tablet | Is a | False | Erlotinib-containing product in oral dose form | Inferred relationship | Some | |
Erlotinib (as erlotinib hydrochloride) 150 mg oral tablet | Is a | False | Erlotinib-containing product in oral dose form | Inferred relationship | Some | |
Erlotinib (as erlotinib hydrochloride) 25 mg oral tablet | Is a | False | Erlotinib-containing product in oral dose form | Inferred relationship | Some |
Reference Sets
Australian dialect reference set